The benefits of Clopidogrel on the treatment of acute coronary syndromes are well established. However, not all patients respond in the same way to Clopidogrel therapy, and there are patients who suffer major adverse cardiovascular events despite being on treatment, emerging the concept of Clopidogrel resistance. This book focuses on this topic, mainly in the definition, response assessment, clinical implications, patients management and emerging therapies (prasugrel, cangrelor and ticagrelor).
Introduction; Resistance/Variable Response to Clopidogrel. Does It Exist?; Mechanisms of Variable Response to Clopidogrel; Is it Possible to Accurately Assess the Inhibitory Effect of Antiplatelt Drugs?; Clinical Implications of Variable Response to Clopidogrel; What to Do with Patients with Reduced Response to Clopidogrel Therapy?; Emerging Therapies; Index.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.